PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.93%
Revenue growth 50-75% of ORCL's 36.53%. Martin Whitman would scrutinize if slower growth is temporary.
No Data
No Data available this quarter, please select a different quarter.
18.93%
Gross profit growth 50-75% of ORCL's 36.53%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.93%
EBITDA growth 50-75% of ORCL's 36.53%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
18.93%
Operating income growth 50-75% of ORCL's 36.53%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
-18.93%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
EPS change of 100.00% while ORCL is flat. Bruce Berkowitz would examine quality.
100.00%
Diluted EPS change of 100.00% while ORCL is flat. Bruce Berkowitz would examine quality.
0.42%
Share count reduction exceeding 1.5x ORCL's 3.40%. David Dodd would verify capital allocation.
0.42%
Diluted share reduction exceeding 1.5x ORCL's 3.40%. David Dodd would verify capital allocation.